Dental Pulp Exposure
10
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (10)
Comparative Evaluation of Clinical and Radiographic Outcomes of Mustard Gel (Brassica Nigra) and Mineral Trioxide Aggregate (MTA) as Pulpotomy Agents in Deciduous Molars- A Randomized Controlled Trial
Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth
Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial
Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth
Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA
The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy
MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial
The Effect of Laser Combined With Pulp-capping Agents on Direct Pulp Capping
Pulp Capping With Two Different Agents
Human Pulpal Response After Pulp Capping With Four Different Agents